Current levels of conflict of interest disclosure in medical publications from korea

Journal of Korean Medical Science

Volumn 28, Issue 7, 2013, Pages 978-982

  Kang, Bo Hyoung ^a   Moon, Jae Young ^a   Chang, Youjin ^a   Koo, Young Mo ^a   Koh, Younsuck ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Biomedical research; Conflict of interest; Editorial policies; Ethical analysis

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; ETHICS; INTERPERSONAL COMMUNICATION; MEDICAL RESEARCH; PUBLICATION; PUBLISHING; SOUTH KOREA;

BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; EDITORIAL POLICIES; ETHICAL ANALYSIS;

CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES; PERIODICALS AS TOPIC; PUBLISHING; REPUBLIC OF KOREA;

EID: 84880799288     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.7.978     Document Type: Article

References (14)

1. Bell CM, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greenberg D, Neumann PJ. Bias in published cost effectiveness studies: systematic review. BMJ 2006; 332: 699-703.
2. Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004; 170: 477-80.
3. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289: 454-65.
4. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167-70.
5. Sismondo S. Pharmaceutical company funding and its consequences: a qualitative systematic review. Contemp Clin Trials 2008; 29: 109-13.
6. Morin K, Rakatansky H, Riddick FA Jr, Morse LJ, O'Bannon JM 3rd, Goldrich MS, Ray P, Weiss M, Sade RM, Spillman MA. Managing conflicts of interest in the conduct of clinical trials. JAMA 2002; 287: 78-84.
7. Blum JA, Freeman K, Dart RC, Cooper RJ. Requirements and definitions in conflict of interest policies of medical journals. JAMA 2009; 302: 2230-4.
8. Flanagin A, Fontanarosa PB, DeAngelis CD. Update on JAMA's conflict of interest policy. JAMA 2006; 296: 220-1.
9. Horton R. A statement by the editors of the Lancet. Lancet 2004; 363: 820-1.
10. Beyer T, Czernin J. Is conflict of interest in our best interest?. Eur J Nucl Med Mol Imaging 2010; 37: 1063-8.
11. Wikipedia. Conflict of interest 2012. Available at http://en.wikipedia. org/wiki/conflict [accessed on 11 October 2012].
12. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 2001; 7: 205-18.
13. Schneider N, Lingner H, Schwartz FW. Disclosing conflicts of interest in German publications concerning health services research. BMC Health Serv Res 2007; 7: 78.
14. Miller FG, Shorr AF. Ethical assessment of industry-sponsored clinical trials: a case analysis. Chest 2002; 121: 1337-42.